Drug Transporter (DT) Information

General Information of DT
DT ID DTD0263
Gene Name SLC2A5
Protein Name Glucose transporter type 5, small intestine
Gene ID
6518
UniProt ID
P22732
TCDB ID
2.A.1.1.13
3D Structure

Modelled DT Structure

Method: homology modeling

Template PDB: 4YBQ_A

Identity: 81.312%

Minimized Score: -1280.522 kcal/mol

Detail: Structure Info

Synonyms Fructose transporter; GLUT-5; GLUT5; SLC2A5; Solute carrier family 2, facilitated glucose transporter member 5
DT Family Major Facilitator Superfamily (MFS)
Sugar Porter (SP) Family
Tissue Specificity Detected in skeletal muscle, and in jejunumbrush border membrane and basolateral membrane (at protein level)(PubMed:7619085). Expressed in small intestine, and at much lowerlevels in kidney, skeletal muscle, and adipose tissue.
Function This transporter functions as a fructose transporter that has only low activity with other monosaccharides. Can mediate the uptake of 2-deoxyglucose, but with low efficiency. Essential for fructose uptake in the small intestine. Plays a role in the regulation of salt uptake and blood pressure in response to dietary fructose. Required for the development of high blood pressure in response to high dietary fructose intake.
Endogenous Substrate(s) Fructose; 2-deoxyglucose
Variability Data of This Drug Transporter (DT)

Regulatory Variability Data of This DT (VARIDT 3.0)

(β) Post-translational Modification of This DT
Post-translational Modification (PTM)

(γ) Transcriptional Regulation of This DT
Transcriptional Regulation (TSR)

(δ) Epigenetic Regulation of This DT
Epigenetic Regulation (EGR)

(ε) Exogenous Modulation of This DT
Exogenous Modulation (EGM)

Structural Variability Data of This DT (VARIDT 2.0)

(β) Inter-species Structural Differences
Inter-species Structural Differences (ISD)

(γ) Outward/inward-facing Conformation
Outward/inward-facing Conformation (OIC)

(δ) Xenobiotics-regulated Structural Variability
Xenobiotics-regulated Structural Variability (XSV)

General Variability Data of This DT (VARIDT 1.0)

(β) Disease-specific Protein Abundances of This DT
Disease-specific Protein Abundances of This DT (DPAD)

(γ) Species- and Tissue-specific DT Abundances
Species/Tissue-specific Protein Abundances of This DT (S/TPAD)
Molecular Transporting Profile of This DT

Full List of Drug(s) Transported by This DT

 Approved Drug

 Click to Show/Hide the Full List of Drug:            1 Drugs in Total
Drug Name Highest Status Detail Indication ICD 11 Ref
Fructose
 Approved Drug Info Emesis MD90 [1]
References
1 Dexamethasone sensitizes the neonatal intestine to fructose induction of intestinal fructose transporter (Slc2A5) function. Endocrinology. 2008 Jan;149(1):409-23.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.